2Human JA,Ubbink JB,Jerling JJ,et al.The effect of simvastatin on the plasma antioxidant concentrations in patients with hypercholesterolemia.Clin China Acta,1997,263(1):67-77. 被引量:1
3Pantoni L,Sheikh FG,Namboodiri AMS,et al.Lovastatin and phenylacetate inhibit the induction of nitric oxide synthase and cytokines in rat primary astrocytes,micreoglia,and macrophages.J Clin Invest,1997,100(11):2671-2679. 被引量:1
3Stenestrand U, Wallentin L. Early statin treatment following acute myocardial infarction and 1-year survival. JAMA,2001,288:430-436. 被引量:2
4Thompso PT. Clinical relevance of statins: instituting treatment early in caute coronary syndrome patients. Atherosclerosis, 2001, 2 Suppl:15-19. 被引量:2
5Aronow HD, Topol EJ, Roe MT, et al. Effects of lipid-lowering therpay on early mortality after acute coronary syndromes: an observational study. Lancet, 2001, 357:1063-1068. 被引量:2
6Spencer FA, Allegrone J, Goldberg RJ, et al. Association of statin therapy with outcomes of acute coronary syndrome: The GRACE study. Ann Intern Med, 2004, 140:857-866. 被引量:2
7Schwartz GG, Olsson AG, Ezekowitz MD, et al. Effects of atorvastain on early recurrent ischemic events in acute ccoronary syndromes: the MIRACLE study. Arandomized controlled trial. JAMA, 2001, 285:1711-1718. 被引量:1
8Cannon CP, I Braunwald E, McCabe C, et al. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med, 2004, 350:1495-504. 被引量:1
9de Lemos JA,Blazing MA,Wiviott SD et al. Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes.JAMA, 2004, 292:1307-1316. 被引量:1
10Nissen SE. High-dose statins in acute coronary syndromes.Not just lipid levels. JAMA, 2004, l 292:1365-1367. 被引量:1